Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Electrophysiology Ablation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Electrophysiology Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart’s abnormal rhythm.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Electrophysiology Ablation Catheters under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Electrophysiology Ablation Catheters Overview
4 Products under Development
4.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development
4.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment
4.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory
4.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path
4.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date
7.1 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
7.2 Mar 04, 2024: Medtronic Receives 510(k) Clearance for OsteoCool 2.0 RF Ablation System
7.3 Mar 04, 2024: Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
7.4 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
7.5 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
7.6 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
7.7 Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees
7.8 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences
7.9 Feb 06, 2024: INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results
7.1 Feb 01, 2024: S4 Medical Announces Publication of EASY AF Clinical Study Results Showing Significant Esophageal Injury Reduction in JACC: Electrophysiology
7.11 Feb 01, 2024: Japan Lifeline Announces an Appointment of a New Operating Officer
7.12 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
7.13 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024
7.14 Jan 08, 2024: Stereotaxis Announces First Patients Successfully Treated using MAGiC Ablation Catheter
7.15 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
7.16 Dec 14, 2023: Biosense Webster Begins Enrollment of SmartPulse Study in the U.S. to Evaluate RF and PFA Dual Energy Catheter to Treat Atrial Fibrillation
7.17 Dec 11, 2023: MicroPort Scientific : Voluntary Announcement
7.18 Dec 01, 2023: Japan Lifeline Announces Changes in Organization and Personnel
7.19 Nov 10, 2023: Microport Appointment of Director
7.2 Nov 06, 2023: MicroPort EP Participates in LAHRS 2023
7.21 Nov 04, 2023: MicroPort EP Participates in 2023 World Congress of Arrhythmias
7.22 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results
7.23 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
7.24 Oct 04, 2023: Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
7.25 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
7.27 Sep 19, 2023: Microport EP Receives Approval for Firemagic Trueforce Ablation Catheter in EU and UK
7.28 Sep 14, 2023: Adagio announces first procedure with vCLAS catheter system
7.29 Sep 14, 2023: Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market
7.3 Sep 01, 2023: Japan Lifeline Announces Changes in Organizations and Personnel
7.31 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.32 Aug 23, 2023: Boston Scientific Obtains Pre-Market Approval (PMA) for POLARx FIT Cryoablation Balloon Catheter
7.33 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
7.34 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
7.35 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.36 Aug 07, 2023: FDA approves J&J’s Afib ablation devices for use without fluoroscopy
7.37 Jul 19, 2023: Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe
7.38 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
7.39 Jul 18, 2023: Imricor Receives US$1 Million Commitment Letter from North Dakota Development Fund
7.4 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
7.41 Jul 02, 2023: Imricor Signs Landmark Agreement With Leading Distributor In Saudi Arabia
7.42 Jun 15, 2023: Stereotaxis to Initiate First-In-Human Trial to Support CE Mark Application of Magic Catheter
7.43 Jun 09, 2023: MicroPort EP Exhibiting at the Heart Rhythm Society Annual Meeting
7.44 May 18, 2023: MicroPort CRM and MicroPort EP were presented at the 2023 Annual Meeting of the European Heart Rhythm Association
7.45 May 15, 2023: New data published on Biosense Webster QDOT MICRO catheter - the latest advancement in Focal RF ablation for treating AFib
7.46 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.47 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer
7.48 Apr 26, 2023: MicroPort announces annual results for 2022
Table 40: Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Implementation of the HELIOSTAR in Real-world Clinical Practice at a High-volume Center - Operator Learning Curve and Procedural Outcome Parameters
Table 42: Thermocool Smarttouch SF Dual Energy Catheter - Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation (PAF)
Table 57: HeartLight X3 System - A Prospective Multicenter U.S. Comparison of Radiofrequency, Cryoballoon and Laser Balloon Modalities for Pulmonary Vein Isolation Ablation in Patients with Atrial Fibrillation
Table 91: CryoTherapeutics SA - Ongoing Clinical Trials Overview
Table 92: Cryotherapy System - Coronary Artery Disease - Clinical Investigation of Intracoronary Cryotherapy Using the CryoTherapy System (CTS) for High-risk Plaque in Patients with Non-ST Segment Elevation Myocardial Infarction (NSTEMI) or Unstable Angina
Table 180: Shanghai MicroPort EP MedTech Co Ltd - Ongoing Clinical Trials Overview
Table 181: Contact Force-Sensing RF Ablation Catheter - A Multicenter Clinical Study of Pulsed Electric Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter for the Treatment of Paroxysmal Supraventricular Tachycardia Under the Guidance of Columbus 3D EP Navigation System
Table 182: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 6